Rare diseases
Investigational molecules
Locations
Back to Spain92 clinical trials in Marbella, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia
SpainStudy of pirtobrutinib, venetoclax and rituximab combination compared to venetoclax and rituximab in previously treated Chronic Lymphocytic Leukemia patients
SpainStudy on the Effectiveness and Safety of Ibrutinib and Rituximab for Patients with Indolent Mantle Cell Lymphoma
SpainStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
SpainStudy on the Effectiveness and Safety of Trastuzumab, Tucatinib, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer
SpainStudy on Allogenic Stem Cells and Amniotic Membrane for Patients with Advanced Corneal Ulcers Unresponsive to Standard Treatment
SpainStudy on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection
SpainStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
SpainStudy on the Effectiveness of Albaconazole and Fluconazole for Treating Acute Vaginal Yeast Infections in Women
SpainStudy on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment
SpainStudy on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients
SpainStudy on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on lymphomas and breast cancer treatments, including innovative combination therapies for various stages of disease progression.
Advanced clinical trials evaluating novel therapeutic combinations and targeted treatments for improved patient outcomes.
Comprehensive research into pulmonary hypertension and chronic respiratory conditions, testing new therapeutic approaches.
Evaluation of innovative inhaler technologies and long-term treatment efficacy studies.
Studies addressing various infections including herpes simplex and bacterial infections, with focus on treatment optimization.
Development of targeted immunotherapies and evaluation of treatment durations for better patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
